+151.8%
MRNA vs RF
+11.1%
+140.7%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 6mo.
| Period | Portfolio | RF | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -0.1% | -2.2% | -2.4% |
| 7D | +5.5% | +1.3% | +4.2% | +8.8% |
| 30D | +158.7% | -3.6% | +162.3% | +152.0% |
| 3M | +182.1% | +8.1% | +174.0% | +161.0% |
| 6M | +151.8% | +11.5% | +140.3% | +127.3% |
| All | +151.8% | +11.1% | +140.7% | +127.3% |
Cumulative growth
Daily Returns
Daily percentage return beside RF.
Daily Out/Under-Performance
Portfolio return minus RF return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × RF return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 6mo: compounded portfolio wealth divided by compounded RF wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
6mo analysis · Full analysis span regression · 6 months rolling